BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 27973394)

  • 1. Abnormal Mitochondrial cAMP/PKA Signaling Is Involved in Sepsis-Induced Mitochondrial and Myocardial Dysfunction.
    Neviere R; Delguste F; Durand A; Inamo J; Boulanger E; Preau S
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A.
    Módis K; Panopoulos P; Coletta C; Papapetropoulos A; Szabo C
    Biochem Pharmacol; 2013 Nov; 86(9):1311-9. PubMed ID: 24012591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of ovariectomy on cardiac excitation-contraction coupling is mediated through cAMP/PKA-dependent mechanisms.
    Parks RJ; Bogachev O; Mackasey M; Ray G; Rose RA; Howlett SE
    J Mol Cell Cardiol; 2017 Oct; 111():51-60. PubMed ID: 28778766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic diameter influences the rate and magnitude of hippocampal cAMP and PKA transients during β-adrenergic receptor activation.
    Luczak V; Blackwell KT; Abel T; Girault JA; Gervasi N
    Neurobiol Learn Mem; 2017 Feb; 138():10-20. PubMed ID: 27523748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic-cholinoceptor mediated attenuation of phospholamban phosphorylation induced by inhibition of phosphodiesterase in ventricular cardiomyocytes: evidence against a cAMP-dependent effect.
    Gupta RC; Neumann J; Watanabe AM; Sabbah HN
    Mol Cell Biochem; 1998 Oct; 187(1-2):155-61. PubMed ID: 9788753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of oxidative phosphorylation by calcium in cardiac mitochondria is not influenced by cAMP and PKA activity.
    Covian R; French S; Kusnetz H; Balaban RS
    Biochim Biophys Acta; 2014 Dec; 1837(12):1913-1921. PubMed ID: 25178840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
    Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
    FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble adenylyl cyclase-mediated cAMP signaling and the putative role of PKA and EPAC in cerebral mitochondrial function.
    Jakobsen E; Lange SC; Bak LK
    J Neurosci Res; 2019 Aug; 97(8):1018-1038. PubMed ID: 31172581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor.
    De Arcangelis V; Soto D; Xiang Y
    Mol Pharmacol; 2008 Nov; 74(5):1453-62. PubMed ID: 18703669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
    Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
    J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways.
    Moon EY; Lee GH; Lee MS; Kim HM; Lee JW
    Life Sci; 2012 Feb; 90(9-10):373-80. PubMed ID: 22227470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress induced mitochondrial protein kinase A mediates cytochrome c oxidase dysfunction.
    Srinivasan S; Spear J; Chandran K; Joseph J; Kalyanaraman B; Avadhani NG
    PLoS One; 2013; 8(10):e77129. PubMed ID: 24130844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic adenosine monophosphate-phosphodiesterase inhibitors reduce skeletal muscle protein catabolism in septic rats.
    Lira EC; Graca FA; Goncalves DA; Zanon NM; Baviera AM; Strindberg L; Lönnroth P; Migliorini RH; Kettelhut IC; Navegantes LC
    Shock; 2007 Jun; 27(6):687-94. PubMed ID: 17505310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction.
    Mougenot N; Mika D; Czibik G; Marcos E; Abid S; Houssaini A; Vallin B; Guellich A; Mehel H; Sawaki D; Vandecasteele G; Fischmeister R; Hajjar RJ; Dubois-Randé JL; Limon I; Adnot S; Derumeaux G; Lipskaia L
    Cardiovasc Res; 2019 Oct; 115(12):1778-1790. PubMed ID: 30605506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opposite effects of cyclic AMP-protein kinase a signal transduction pathway on renal cortical and medullary Na+,K+-ATPase activity.
    Bełtowski J; Marciniak A; Wójcicka G; Górny D
    J Physiol Pharmacol; 2002 Jun; 53(2):211-31. PubMed ID: 12120897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration.
    Palorini R; De Rasmo D; Gaviraghi M; Sala Danna L; Signorile A; Cirulli C; Chiaradonna F; Alberghina L; Papa S
    Oncogene; 2013 Jan; 32(3):352-62. PubMed ID: 22410778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts.
    Liu S; Li Y; Kim S; Fu Q; Parikh D; Sridhar B; Shi Q; Zhang X; Guan Y; Chen X; Xiang YK
    Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6578-83. PubMed ID: 22493261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway.
    Chen L; Liu K; Wang Y; Liu N; Yao M; Hu J; Wang G; Sun Y; Pan J
    Eur J Pharmacol; 2021 Jan; 891():173768. PubMed ID: 33271150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isobutylmethylxanthine and other classical cyclic nucleotide phosphodiesterase inhibitors affect cAMP-dependent protein kinase activity.
    Tomes C; Rossi S; Moreno S
    Cell Signal; 1993 Sep; 5(5):615-21. PubMed ID: 7508732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.